Paragon Bioservices plans to open a new 150,000 square-foot facility to help fulfill a growing demand for the company’s gene therapy manufacturing services, says CEO.
SQN Clinical has launched SQN Health, a mobile electronic Patient Reported Outcomes (ePRO) and Clinical Outcome Assessment (eCOA) application, which provides real-time and ongoing patient and data oversight.
The US Government shutdown only lasted one working day but the US FDA could take weeks to make up the lost time according to the Alliance for a Stronger FDA.
Apotex has recalled a batch its diabetes drug APO-Metformin XR in Australia after a pill was plastic from a cable or zip tie was found embedded in a pill.
Scientists say a modified plant extract traditionally used as an arrow poison in eastern Africa could inhibit sperm cells’ ability to swim, and lead to the development of a male contraceptive pill.
The Access to Medicines Foundation has launched a ‘benchmark’ that maps drug industry efforts to stem the spread of drug resistance at the World Economic Forum in Davos, Switzerland.
